Application of ultrasonography to Neuro-COVID-19

Aim: The aim of this study is to evaluate the role ultrasonography in diagnosis and treatment COVID-19, disease caused by severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), with particular reference symptoms that are frequently observed Neuro-COVID-19, a term indicates plethora short- long-term neurologic psychiatric manifestations by, or associated disease. In significant percentage cases, neuro-psychiatric persist after recovery sequelae have been reported. SARS-CoV-2 can infect brain through different routes damage be direct, due virus itself, indirect, abnormal immune responses, inflammation, hypoxia. Methods: study, was studied transcranial ultrasonography. Analysis specimens obtained from autopsy demonstrated presence minority cases leads hypothesize may hide sanctuary sites central nervous system analogy what for HIV. existence has potential decrease efficacy antiviral therapies vaccination even prevent complete eradication infected organism. Results: Transcranial movements cycle. 2017, diagnostic therapeutic procedure proposed goal identifying treating pathogens hiding sanctuaries elude therapy. This based on clinical evaluation, ultrasonography, ultrasounds, laboratory analyses. Conclusions: Here, it application Neuro-COVID-19 requires specific adaptation takes into account synchronous breathing as well sensitivity ultrasounds.